BLLN: BillionToOne, Inc.
Performance
BLLN +14.92%
Watchlist
Select an item
Summary
BLLN at a glance
BLLN returned +14.92% over the past year. Its worst drop in that year was -50.81%, smaller than 22% of stocks on Redstone, and its Sharpe ratio of 0.58 beats 55% of stocks on Redstone. It pays no dividends.
Current Drawdown
-23.35%
Rolling Volatility
40.15%
Actions
Metrics
Risk Indicators
Alpha36.16%
Beta1.48x
Sharpe0.58
Sortino0.79
Omega1.11
Calmar0.29
Martin1.68
Profile
About BLLN
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform.
- Sector
- Health Care
- Industry
- Services: Medical Laboratories
- Market cap
- $5.4B
- Listed
- Nov 2025
- Employees
- 713
- Headquarters
- Menlo Park, CA
- Website
- billiontoone.com
Comparisons